OA
Oak Associates Portfolio holdings
AUM
$1.53B
1-Year Return
20.93%
This Quarter Return
+10.05%
1 Year Return
+20.93%
3 Year Return
+113.44%
5 Year Return
+164.39%
10 Year Return
+515.4%
AUM
$1.7B
AUM Growth
+$76.5M
(+4.7%)
Cap. Flow
-$71.9M
Cap. Flow
% of AUM
-4.24%
Top 10 Holdings %
Top 10 Hldgs %
38.88%
Holding
155
New
10
Increased
23
Reduced
65
Closed
6
Top Buys
| 1 |
Visa
V
|
$15M |
| 2 |
Skyworks Solutions
SWKS
|
$4.43M |
| 3 |
Bristol-Myers Squibb
BMY
|
$2.01M |
| 4 |
Jack Henry & Associates
JKHY
|
$1.87M |
| 5 |
PayPal
PYPL
|
$1.65M |
Top Sells
| 1 |
KLA
KLAC
|
$16.4M |
| 2 |
IAC Inc
IAC
|
$10.2M |
| 3 |
Apple
AAPL
|
$6.95M |
| 4 |
Bread Financial
BFH
|
$5.63M |
| 5 |
H&R Block
HRB
|
$5.42M |
Sector Composition
| 1 | Technology | 41.25% |
| 2 | Healthcare | 15.26% |
| 3 | Communication Services | 13.12% |
| 4 | Financials | 12.5% |
| 5 | Consumer Discretionary | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Akamai
AKAM
$11.3B
| $10.5M | 0.62% |
121,370
-15,000
| -11% | -$1.3M |
|
52
Gentex
GNTX
$6.25B
| $9.77M | 0.58% |
337,130
+8,015
| +2% | +$232K |
|
|
CIT
53
DELISTED
CIT Group Inc.
CIT
| $9.03M | 0.53% |
197,882
-97,252
| -33% | -$4.44M |
|
54
Medtronic
MDT
$119B
| $9M | 0.53% |
79,316
| – | – |
|
55
Travelers Companies
TRV
$62B
| $8.82M | 0.52% |
64,388
-10
| -0% | -$1.37K |
|
56
McKesson
MCK
$85.5B
| $8.15M | 0.48% |
58,952
-1,700
| -3% | -$235K |
|
57
Hewlett Packard
HPE
$31B
| $7.65M | 0.45% |
482,266
| – | – |
|
58
Salesforce
CRM
$239B
| $7.32M | 0.43% |
45,020
-1,305
| -3% | -$212K |
|
59
Corning
GLW
$61B
| $7.14M | 0.42% |
245,314
+2
| +0% | +$58 |
|
60
Biogen
BIIB
$20.6B
| $6.53M | 0.38% |
21,998
-2,150
| -9% | -$638K |
|
61
Wells Fargo
WFC
$253B
| $6.5M | 0.38% |
120,737
-97
| -0.1% | -$5.22K |
|
62
Western Union
WU
$2.86B
| $6.31M | 0.37% |
235,440
-60
| -0% | -$1.61K |
|
63
Synchrony
SYF
$28.1B
| $6.15M | 0.36% |
170,820
-35
| -0% | -$1.26K |
|
64
Assurant
AIZ
$10.7B
| $5.82M | 0.34% |
44,410
-2,235
| -5% | -$293K |
|
|
RDS.A
65
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $4.93M | 0.29% |
83,600
-15
| -0% | -$885 |
|
66
Quest Diagnostics
DGX
$20.5B
| $4.35M | 0.26% |
40,700
+2,245
| +6% | +$240K |
|
67
Cardinal Health
CAH
$35.7B
| $3.83M | 0.23% |
75,680
+1,730
| +2% | +$87.5K |
|
68
Waters Corp
WAT
$18.2B
| $3.21M | 0.19% |
13,740
| – | – |
|
69
Sanofi
SNY
$113B
| $3.18M | 0.19% |
63,420
-15
| -0% | -$753 |
|
70
Novo Nordisk
NVO
$245B
| $2.97M | 0.17% |
102,480
| – | – |
|
71
Everest Group
EG
$14.3B
| $2.94M | 0.17% |
10,600
-10
| -0.1% | -$2.77K |
|
72
Charles River Laboratories
CRL
$8.07B
| $2.75M | 0.16% |
17,995
| – | – |
|
73
UnitedHealth
UNH
$286B
| $2.72M | 0.16% |
9,250
| – | – |
|
74
JPMorgan Chase
JPM
$809B
| $2.37M | 0.14% |
17,025
+25
| +0.1% | +$3.49K |
|
75
Merck
MRK
$212B
| $2.35M | 0.14% |
27,059
| – | – |
|